INDRAYANI BIOTECH LTD.

NSE : NABSE : 526445ISIN CODE : INE007C01021Industry : FloricultureHouse : Private
BSE49.17-1.64 (-3.23 %)
PREV CLOSE ( ) 50.81
OPEN PRICE ( ) 52.89
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 136262
TODAY'S LOW / HIGH ( )48.27 52.89
52 WK LOW / HIGH ( ) 46.899.7
NSE
This Company is not listed in NSE
( in Million)
Select year
ParticularsMar2023Mar2022Mar2021Mar2020Mar2012
Profit Before Tax119.3144.40-112.148.070.26
Adjustment93.7125.2445.2421.245.96
Changes In working Capital-51.14-28.5369.4730.2810.71
Cash Flow after changes in Working Capital161.8841.112.5659.5916.93
Cash Flow from Operating Activities161.8841.112.5659.5916.70
Cash Flow from Investing Activities-473.94-5.58-7.02-36.66-0.61
Cash Flow from Financing Activities327.39-27.30-2.77-12.82-6.56
Net Cash Inflow / Outflow15.338.23-7.2410.119.54
Opening Cash & Cash Equivalents15.036.7914.023.912.41
Cash & Cash Equivalent on Amalgamation / Take over / MergerNANANANANA
Cash & Cash Equivalent of Subsidiaries under liquidationsNANANANANA
Translation adjustment on reserves / op cash balalces frgn subsidiariesNANANANANA
Effect of Foreign Exchange FluctuationsNANANANANA
Closing Cash & Cash Equivalent30.3715.026.7914.0211.95

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.